Caring for Patients with Chronic Myeloid Leukemia (CML) Receiving Tyrosine Kinase Inhibitor (TKI) Therapy in an Era of Evolving Treatment Goals

Autor:	Lisa A. Nodzon, Sara Tinsley
Rok vydání:	2018
Předmět:	Cancer Research Oncology business.industry medicine.drug_class Cancer research Medicine Myeloid leukemia Hematology Treatment goals business Tyrosine-kinase inhibitor
Zdroj:	Clinical Lymphoma Myeloma and Leukemia. 18:S224-S225
ISSN:	2152-2650
DOI:	10.1016/j.clml.2018.07.096
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d609d4186660d89f62c482a824e79f2c https://doi.org/10.1016/j.clml.2018.07.096 Zobrazit plný text záznamu Full Text from ScienceDirect